1. Home
  2. MCS vs UPB Comparison

MCS vs UPB Comparison

Compare MCS & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCS
  • UPB
  • Stock Information
  • Founded
  • MCS 1935
  • UPB 2021
  • Country
  • MCS United States
  • UPB United States
  • Employees
  • MCS N/A
  • UPB N/A
  • Industry
  • MCS Movies/Entertainment
  • UPB
  • Sector
  • MCS Consumer Discretionary
  • UPB
  • Exchange
  • MCS Nasdaq
  • UPB NYSE
  • Market Cap
  • MCS 537.6M
  • UPB 521.3M
  • IPO Year
  • MCS N/A
  • UPB 2024
  • Fundamental
  • Price
  • MCS $16.93
  • UPB $8.82
  • Analyst Decision
  • MCS Strong Buy
  • UPB Strong Buy
  • Analyst Count
  • MCS 4
  • UPB 4
  • Target Price
  • MCS $23.75
  • UPB $56.50
  • AVG Volume (30 Days)
  • MCS 161.8K
  • UPB 333.8K
  • Earning Date
  • MCS 05-06-2025
  • UPB 05-06-2025
  • Dividend Yield
  • MCS 1.65%
  • UPB N/A
  • EPS Growth
  • MCS N/A
  • UPB N/A
  • EPS
  • MCS N/A
  • UPB N/A
  • Revenue
  • MCS $704,626,000.00
  • UPB $2,296,000.00
  • Revenue This Year
  • MCS $11.30
  • UPB N/A
  • Revenue Next Year
  • MCS $5.20
  • UPB $0.99
  • P/E Ratio
  • MCS N/A
  • UPB N/A
  • Revenue Growth
  • MCS 3.81
  • UPB N/A
  • 52 Week Low
  • MCS $9.56
  • UPB $5.14
  • 52 Week High
  • MCS $23.16
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • MCS 54.66
  • UPB N/A
  • Support Level
  • MCS $15.42
  • UPB N/A
  • Resistance Level
  • MCS $16.98
  • UPB N/A
  • Average True Range (ATR)
  • MCS 0.44
  • UPB 0.00
  • MACD
  • MCS 0.11
  • UPB 0.00
  • Stochastic Oscillator
  • MCS 89.88
  • UPB 0.00

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

Share on Social Networks: